Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

PINC vs DBVT vs ALKS vs OMI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PINC
Premier, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$2.34B
5Y Perf.-18.8%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-69.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+87.7%
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-49.9%

PINC vs DBVT vs ALKS vs OMI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PINC logoPINC
DBVT logoDBVT
ALKS logoALKS
OMI logoOMI
IndustryMedical - Healthcare Information ServicesBiotechnologyBiotechnologyMedical - Distribution
Market Cap$2.34B$1712.35T$5.90B$171M
Revenue (TTM)$1.00B$0.00$1.56B$2.76B
Net Income (TTM)$-24M$-168M$153M$-1.10B
Gross Margin72.6%65.4%
Operating Margin-0.0%12.3%1.0%
Forward P/E20.8x24.8x2.3x
Total Debt$282M$22M$70M$320M
Cash & Equiv.$84M$194M$1.12B$282M

PINC vs DBVT vs ALKS vs OMILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PINC
DBVT
ALKS
OMI
StockMay 20Nov 25Return
Premier, Inc. (PINC)10081.2-18.8%
DBV Technologies S.… (DBVT)10030.2-69.8%
Alkermes plc (ALKS)100187.7+87.7%
Owens & Minor, Inc. (OMI)10050.1-49.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: PINC vs DBVT vs ALKS vs OMI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Premier, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. DBVT and OMI also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
PINC
Premier, Inc.
The Income Pick

PINC is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 1 yrs, beta 0.07, yield 3.0%
  • -4.6% 10Y total return vs ALKS's -11.0%
  • Beta 0.07, yield 3.0%, current ratio 0.64x
  • Beta 0.07 vs OMI's 1.44
Best for: income & stability and long-term compounding
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.4% vs OMI's -71.1%
Best for: momentum
ALKS
Alkermes plc
The Growth Play

ALKS carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • -5.2% revenue growth vs DBVT's -100.0%
  • 9.8% margin vs OMI's -39.8%
Best for: growth exposure and sleep-well-at-night
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 24.8x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthALKS logoALKS-5.2% revenue growth vs DBVT's -100.0%
ValueOMI logoOMILower P/E (2.3x vs 24.8x)
Quality / MarginsALKS logoALKS9.8% margin vs OMI's -39.8%
Stability / SafetyPINC logoPINCBeta 0.07 vs OMI's 1.44
DividendsPINC logoPINC3.0% yield; 1-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs OMI's -71.1%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

PINC vs DBVT vs ALKS vs OMI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PINCPremier, Inc.
FY 2025
Administrative Fees
100.0%$556M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M

PINC vs DBVT vs ALKS vs OMI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPINCLAGGINGOMI

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

OMI and DBVT operate at a comparable scale, with $2.8B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to OMI's -39.8%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
RevenueTrailing 12 months$1.0B$0$1.6B$2.8B
EBITDAEarnings before interest/tax$118M-$112M$212M$277M
Net IncomeAfter-tax profit-$24M-$168M$153M-$1.1B
Free Cash FlowCash after capex$265M-$151M$392M-$353M
Gross MarginGross profit ÷ Revenue+72.6%+65.4%
Operating MarginEBIT ÷ Revenue-0.0%+12.3%+1.0%
Net MarginNet income ÷ Revenue-2.4%+9.8%-39.8%
FCF MarginFCF ÷ Revenue+26.4%+25.1%-12.8%
Rev. Growth (YoY)Latest quarter vs prior year-3.3%+28.2%-146.3%
EPS Growth (YoY)Latest quarter vs prior year-70.0%+91.5%-4.1%+4.5%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

OMI leads this category, winning 3 of 6 comparable metrics.

At 24.8x trailing earnings, ALKS trades at a 81% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than PINC's 21.3x.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
Market CapShares × price$2.3B$1712.35T$5.9B$171M
Enterprise ValueMkt cap + debt − cash$2.5B$1712.35T$4.9B$209M
Trailing P/EPrice ÷ TTM EPS128.45x-0.76x24.76x-0.16x
Forward P/EPrice ÷ next-FY EPS est.20.79x2.31x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple21.35x17.25x1.70x
Price / SalesMarket cap ÷ Revenue2.31x4.00x0.06x
Price / BookPrice ÷ Book value/share1.70x0.66x3.28x
Price / FCFMarket cap ÷ FCF7.33x12.28x
OMI leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-21 for OMI. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to PINC's 0.18x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs OMI's 2/9, reflecting strong financial health.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
ROE (TTM)Return on equity-1.6%-130.2%+8.8%-21.1%
ROA (TTM)Return on assets-0.8%-89.0%+5.4%-44.9%
ROICReturn on invested capital+0.0%+18.9%+1.8%
ROCEReturn on capital employed+0.0%-145.7%+14.2%+1.3%
Piotroski ScoreFundamental quality 0–94472
Debt / EquityFinancial leverage0.18x0.13x0.04x
Net DebtTotal debt minus cash$198M-$172M-$1.0B$38M
Cash & Equiv.Liquid assets$84M$194M$1.1B$282M
Total DebtShort + long-term debt$282M$22M$70M$320M
Interest CoverageEBIT ÷ Interest expense1.13x-189.82x32.30x-0.12x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, DBVT leads with a +110.4% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs OMI's -49.9% — a key indicator of consistent wealth creation.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
YTD ReturnYear-to-date+4.9%+25.3%-3.4%
1-Year ReturnPast 12 months+24.0%+110.4%+16.5%-71.1%
3-Year ReturnCumulative with dividends+14.8%+19.7%+14.5%-87.4%
5-Year ReturnCumulative with dividends-9.2%-69.1%+60.9%-93.5%
10-Year ReturnCumulative with dividends-4.6%-87.0%-11.0%-86.2%
CAGR (3Y)Annualised 3-year return+4.7%+6.2%+4.6%-49.9%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

PINC leads this category, winning 2 of 2 comparable metrics.

PINC is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
Beta (5Y)Sensitivity to S&P 5000.21x1.26x1.00x1.45x
52-Week HighHighest price in past year$28.79$26.18$36.60$9.55
52-Week LowLowest price in past year$20.62$7.53$25.17$1.84
% of 52W HighCurrent price vs 52-week peak+98.2%+76.3%+96.7%+23.5%
RSI (14)Momentum oscillator 0–10065.048.160.246.5
Avg Volume (50D)Average daily shares traded0252K2.3M690K
PINC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PINC leads this category, winning 1 of 1 comparable metric.

Analyst consensus: PINC as "Hold", DBVT as "Buy", ALKS as "Buy", OMI as "Hold". Consensus price targets imply 596.4% upside for OMI (target: $16) vs 17.3% for PINC (target: $33). PINC is the only dividend payer here at 2.98% yield — a key consideration for income-focused portfolios.

MetricPINC logoPINCPremier, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcOMI logoOMIOwens & Minor, In…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$33.15$46.33$46.00$15.60
# AnalystsCovering analysts31152810
Dividend YieldAnnual dividend ÷ price+3.0%
Dividend StreakConsecutive years of raises1000
Dividend / ShareAnnual DPS$0.84
Buyback YieldShare repurchases ÷ mkt cap+17.1%0.0%+0.5%0.0%
PINC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PINC leads in 2 (Risk & Volatility, Analyst Outlook).

Best OverallPremier, Inc. (PINC)Leads 2 of 6 categories
Loading custom metrics...

PINC vs DBVT vs ALKS vs OMI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PINC or DBVT or ALKS or OMI a better buy right now?

For growth investors, Alkermes plc (ALKS) is the stronger pick with -5.

2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PINC or DBVT or ALKS or OMI?

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus Premier, Inc. at 128. 5x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — PINC or DBVT or ALKS or OMI?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: PINC returned -4. 6% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PINC or DBVT or ALKS or OMI?

By beta (market sensitivity over 5 years), Premier, Inc.

(PINC) is the lower-risk stock at 0. 21β versus Owens & Minor, Inc. 's 1. 45β — meaning OMI is approximately 592% more volatile than PINC relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 18% for Premier, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PINC or DBVT or ALKS or OMI?

By revenue growth (latest reported year), Alkermes plc (ALKS) is pulling ahead at -5.

2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Alkermes plc grew EPS -34. 1% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PINC or DBVT or ALKS or OMI?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PINC or DBVT or ALKS or OMI more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 20. 8x for Premier, Inc. — 18. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 596. 4% to $15. 60.

08

Which pays a better dividend — PINC or DBVT or ALKS or OMI?

In this comparison, PINC (3.

0% yield) pays a dividend. DBVT, ALKS, OMI do not pay a meaningful dividend and should not be held primarily for income.

09

Is PINC or DBVT or ALKS or OMI better for a retirement portfolio?

For long-horizon retirement investors, Premier, Inc.

(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 0% yield). Both have compounded well over 10 years (PINC: -4. 6%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PINC and DBVT and ALKS and OMI?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

PINC pays a dividend while DBVT, ALKS, OMI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PINC

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 43%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.